Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal VISIKES
Nur Ain’ni, Charisma Ayu
Unknown Affiliation
Education

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
MANAJEMEN PENGGUNAAN OBAT ANTIDIABETES ORAL PADA PASIEN DIABETES MELLITUS DI PUSKESMAS KABUPATEN GROBOGAN W.S., F.X. Sulistiyanto; Anggoro, Aloysius Barry; Nur Ain’ni, Charisma Ayu
VISIKES: Jurnal Kesehatan Masyarakat Vol. 22 No. 2 (2023): VISIKES
Publisher : Dian Nuswantoro Semarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33633/visikes.v22i2Supp.9195

Abstract

Diabetes mellitus is a chronic disease in the form of a metabolic disorder characterized by blood sugar levels exceeding normal limits >140 mg/dL. Prevalence data from the International Diabetes Federation (IDF) predicts that there will be 536.6 million adults aged 20-79 years in the world who suffer from diabetes in 2021, or the equivalent of a prevalence rate of 10.5% of the total population at the same age. The success of a disease therapy is not only influenced by the accuracy of the diagnosis, the selection and administration of the right drug, but compliance in the use of drugs is a determinant of success in the therapy of a disease. The purpose of this study was to determine the characteristics and level of adherence to the use of oral antidiabetic drugs in patients with type 2 DM at Grobogan District Health Center. The type of research used is observational research using descriptive methods. Sampling used a purposive sampling technique with a total sample of 100 patients. The data collection instrument used the MMAS-8 questionnaire to see the level of adherence in diabetes mellitus patients. The results of this study indicate that the level of adherence to drug use in type 2 DM patients at Public Health Center was obtained in the "High Compliance" category of 21 patients (53%) in prolanis respondents and the "Medium Compliance" category was obtained in 24 patients (40%) in respondents non prolanis.
Co-Authors Anggoro, Aloysius Barry W.S., F.X. Sulistiyanto